tci Medicare Compliance & Reimbursement - 2005 Issue 20
DME: Inhalation Drug Denials Leave Many Suppliers Gasping
Subscribe or sign in to view the full article.
Article Overview
This article discusses a Medicare durable medical equipment billing issue involving denials related to inhalation drug dispensing and supply fees. It summarizes concerns raised by suppliers, comments from CMS at an Open Door Forum, and a regional carrier notice about claim submission practices. The piece is relevant to DME suppliers, billing staff, and reimbursement professionals tracking Medicare policy enforcement and denial trends.
Why This Topic Matters
Suppliers need to understand why certain inhalation drug-related claims are being denied and what federal and regional Medicare entities have said about the issue. The article provides context for compliance monitoring and claim workflow awareness in DME billing.
What You Will Learn
- What billing issue was raised by DME suppliers regarding inhalation drug claims
- How CMS responded to reported denial concerns involving Medicare contractors
- What type of carrier notice addressed duplicate claim denials for supply fees
- Which Medicare billing stakeholders were involved in the discussion
Who Should Read This
- Durable medical equipment suppliers
- DME billing and reimbursement staff
- Medicare compliance teams
- Revenue cycle professionals
- Home health and hospice billing stakeholders
Codes Discussed
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com